IMC Chicago’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.06M Sell
88,200
-45,900
-34% -$3.78M ﹤0.01% 1531
2025
Q4
$11.4M Sell
134,100
-12,200
-8% -$1M ﹤0.01% 1129
2025
Q3
$11.4M Sell
146,300
-25,400
-15% -$1.98M ﹤0.01% 1087
2025
Q2
$13.4M Buy
171,700
+16,100
+10% +$1.2M 0.01% 883
2025
Q1
$11.3M Buy
155,600
+14,100
+10% +$1.01M 0.01% 837
2024
Q4
$10.5M Buy
141,500
+18,000
+15% +$1.26M ﹤0.01% 890
2024
Q3
$8.15M Buy
123,500
+72,900
+144% +$5.3M ﹤0.01% 914
2024
Q2
$4.67M Sell
50,600
-5,900
-10% -$522K ﹤0.01% 1100
2024
Q1
$5.4M Sell
56,500
-2,600
-4% -$218K ﹤0.01% 938
2023
Q4
$4.51M Sell
59,100
-13,600
-19% -$946K ﹤0.01% 919
2023
Q3
$5.04M Buy
72,700
+39,200
+117% +$3.15M ﹤0.01% 735
2023
Q2
$3.16M Buy
+33,500
New +$2.91M ﹤0.01% 757
2023
Q1
Sell
-15,900
Closed -$1.19M 1302
2022
Q4
$1.19M Buy
15,900
+5,100
+47% +$393K ﹤0.01% 963
2022
Q3
$892K Buy
+10,800
New +$1.04M ﹤0.01% 967
2021
Q1
Sell
-12,700
Closed -$1.16M 1080
2020
Q4
$1.16M Sell
12,700
-4,700
-27% -$390K ﹤0.01% 822
2020
Q3
$1.39M Sell
17,400
-8,900
-34% -$694K ﹤0.01% 656
2020
Q2
$1.82M Sell
26,300
-16,000
-38% -$1.14M ﹤0.01% 584
2020
Q1
$2.66M Buy
+42,300
New +$3.05M 0.01% 446
2019
Q1
Sell
-11,700
Closed -$597K 716
2018
Q4
$597K Buy
+11,700
New +$592K ﹤0.01% 568

Other funds holding EW

IMC Chicago's EW Position: Q1 2026 in Review

IMC Chicago opened a new position in Edwards Lifesciences (EW) in Q1 2026: 9,445 shares worth $756K. The stake represents ﹤0.01% of the portfolio and ranks #3572 among its holdings. This is a return to the name: IMC Chicago previously reported a position in EW as recently as Q2 2025.

IMC Chicago first reported a position in EW in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.92M in Q2 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • IMC Chicago held 9,445 shares of Edwards Lifesciences worth $756K as of Q1 2026.
  • Edwards Lifesciences was a new IMC Chicago position in Q1 2026.
  • Edwards Lifesciences made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3572 holding.
  • IMC Chicago first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 4 quarters since.
  • IMC Chicago's Edwards Lifesciences position peaked at $1.92M in Q2 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.